ClinicalTrials.Veeva

Menu

Cardiovascular Risk After Preeclampsia

Charité University Medicine Berlin logo

Charité University Medicine Berlin

Status

Enrolling

Conditions

Preeclampsia

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Investigation of cardiovascular risk 5-15 years after early or late-onset preeclampsia by adenosine stress Magnetic Resonance Imaging and non-invasive methods like retinal vessel analysis, skin measurement of advanced glycation end products, flow-mediated dilation or pulse wave analysis in comparison to women after healthy pregnancies.

Enrollment

60 estimated patients

Sex

Female

Ages

18 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Women
  • 18-60 years
  • 5-15 years postpartum

Exclusion criteria

  • Atrioventricular block, chronic obstructive pulmonary disease, bronchial asthma
  • Pregnancy and/or active breastfeeding
  • Glaucoma disease, epilepsy
  • In addition for MRI: metal implants, electric devices, intolerance of contrast media, claustrophobia, renal or hepatic dysfunction (GFR < 30 ml/min)

Trial design

60 participants in 3 patient groups

Early-onset preeclampsia
Description:
Defined as preeclampsia that develops before 34 weeks of gestation
Late-onset preeclampsia
Description:
Defined as preeclampsia that develops after 34 weeks of gestation
Control
Description:
Healthy pregnancies, matched to early and late-onset cases

Trial contacts and locations

1

Loading...

Central trial contact

Kristin Kräker, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems